Beluga NV

Beluga NV

EEURONEXT:BELU
0.06
EUR
0.00
(0.00%)
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
Revenue per Share
0.2
0.18
0.19
0.22
0.02
-0.21
- -
0.87
4.2
4.32
4.4
2.67
- -
Basic EPS, GAAP
0.32
-0.04
-0.07
-0.07
0.2
-0.26
-1.62
-0.17
-0.02
-0.07
0.24
1.5
0.2
Free Cash Flow per Basic Share
0.26
0.04
0.07
- -
-0.05
-0.05
-0.23
-0.69
-0.34
-0.15
0.78
1.95
-0.12
Dividend per Share
- -
0.1
0.1
0.1
0.11
0.1
0.04
- -
- -
- -
- -
- -
0.35
Book Value per Share
4.67
4.53
4.36
4.19
4.29
3.94
2.28
2.12
2.1
2.03
2.27
3.77
3.59
Tangible Book Value per Share
4.85
4.72
4.56
4.39
4.49
4.11
2.4
1.99
1.66
1.75
2.1
3.76
3.58
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
1
1
1
1
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
1
6
6
6
4
- -
Operating Margin (%)
-13.75
45.63
-17.58
-8.03
178.79
208.87
-81,500
-19.24
-2.22
-3.7
1.64
-4.02
10,600
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
-2
- -
- -
- -
- -
2
- -
Effective Tax Rate (%)
4.73
- -
- -
- -
9.89
- -
- -
- -
- -
- -
- -
4.86
- -
Profit Margin (%)
163.57
-24.21
-35.94
-31.44
839.39
119.11
-110,400
-20.17
-0.42
-1.66
5.39
56.35
-6,875
Working Capital
4
3
3
2
1
2
2
1
1
1
2
4
4
LT Debt
- -
- -
1
1
- -
- -
- -
- -
1
1
1
- -
- -
Total Equity
7
6
6
6
6
6
3
3
3
3
3
5
5
Return on Invested Capital (%)
- -
- -
- -
- -
0.78
- -
- -
- -
- -
- -
- -
-2.99
- -
Return on Capital (%)
- -
- -
- -
- -
4.88
- -
- -
- -
- -
- -
- -
44.98
- -
Return on Common Equity (%)
- -
-0.97
-1.51
-1.61
4.78
-6.2
-51.92
-7.93
-0.84
-3.49
11.04
49.82
5.48

Capital Structure

EUR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

EUR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.42%
12.95%
-4.76%
Free Cash Flow
-376.54%
-139.07%
-106.3%
Net Income, GAAP
6.15%
47.32%
-86.58%
Sales/Revenue/Turnover
5,798.91%
49.96%
-100.11%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2021
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2021
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2021
- -
- -
- -

Company Description

CEO
Bruno Lippens
Full Time Employees
23
Sector
Finance
Industry
Investment managers
Address
Groeneweg 17 Rixensart Belgium 9320
IPO Date
Jan 4, 2000
Business
Beluga NV (BELU.BR) is a Belgium-based investment company currently in liquidation, specializing in private equity and venture capital investments focused on acquiring and actively managing a diversified portfolio of equity stakes in small and medium-sized enterprises. The firm targets mid-venture, late-venture, middle-market, and mature companies across all sectors, with a primary emphasis on businesses in Belgium, particularly the Flanders region; it provides growth capital, later-stage funding, and buyouts, typically investing between EUR 0.25 million and EUR 2.5 million for minority stakes in companies with enterprise values from EUR 1 million to EUR 250 million, sales between EUR 0.25 million and EUR 500 million, and EBITDA from EUR 1 million to EUR 100 million. Prior to its liquidation process, Beluga invested in sectors including healthcare, B2B services, B2C operations, energy, and financial services, with notable portfolio holdings such as Belovo Flanders for egg science and technology products and La Troupette. Founded in 1998 and headquartered at Rue du Baillois 43 in Rixensart, Belgium, the company sources capital through the stock market and historically operated with a focus on later-stage investments to support portfolio company expansion. Geographically, operations center on Belgium, serving local enterprises in the Flanders and Walloon regions. Beluga previously maintained subsidiaries and investments like Belovo Flanders, part of an international group specializing in functional egg products. In recent major developments within the last two years, Beluga NV entered liquidation proceedings, as announced in its 2023 filings including the audit report on liquidation, special management report dated September 26, 2023, and balance sheet as of July 31, 2023; this followed a delisting announcement and extraordinary general meeting on October 31, 2023, marking a significant operational wind-down and cessation of public financial reporting that had already paused in early 2012. Earlier strategic moves included acquiring the remaining 9.1% stake in Societe De Distribution La Troupette in 2020, increasing ownership to 100% and initiating procedural merger integration, alongside updates on portfolio companies like Belovo in 2019. Insider board transactions continued into late 2023, with significant share purchases by director LONGEVAL in December 2023 totaling over 20,000 shares.